Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study.
Elizabeth A M FeijenJop C TeepenEline van Dulmen-den BroederMarry M van den Heuvel-EibrinkMargriet van der Heiden-van der LooHelena J H van der PalAndrica C H de VriesMarloes LouwerensDorine BrestersBirgitta VersluysHanneke de RidderMargreet VeeningFlora E van LeeuwenMartha GrootenhuisHeleen Maurice-StamHanneke M van SantenSebastian J C M M NeggersSaskia PluijmJaap den HartoghCécile M RonckersWim J E TissingJacqueline J LoonenLeontien C M KremerPublished in: Pediatric blood & cancer (2023)
The high-quality data generated in the LATER 2 study will provide valuable insights into risks of and risk factors for clinical and physical and psychosocial health outcomes and factors for early recognition of those health outcomes in long-term childhood cancer survivors. This will contribute to fill in important gaps in knowledge and improve the quality of life and care for childhood cancer survivors.